BET Bromodomain Inhibitor ZEN-3694

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Castration-Resistant Prostate Carcinoma

Drug Information

Target Indication

Castration-Resistant Prostate Carcinoma

Clinical Trial

Last updated: 8/19/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

MRK

MERCK

Related Pipeline

Hepatitis C, Chronic

Hepatitis C

Rotavirus Gastroenteritis

Heart Failure

HIV-1 Infection

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts